Independent assessment of non invasive liver fibrosis biomarkers in HIV-HCV co-infected patients:: The fibrovic study

被引：0
|
作者：
Cacoub, Patrice
Carrat, Fabrice
Bedossa, Pierre
Lambert, Jerome
Penaranda, Guillaume
Perronne, Christian
Pol, Stanislas
Halfon, Philippe
机构：
[1] Hop La Pitie Salpetriere, Paris, France
[2] Univ Paris 06, Publ Hlth Unit, UMR S707, Paris, France
[3] GHU Est, Paris, France
[4] Beaujon Hosp, Clichy, France
[5] CDL Pharma, Marseille, France
[6] Hop Raymond Poincare, Garches, France
[7] Hop Necker Enfants Malad, Paris, France
[8] Alphabio Lab, Marseille, France
来源：
HEPATOLOGY | 2006年 / 44卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
215
引用
收藏
页码：270A / 270A
页数：1
相关论文
共 50 条
  • [41] Fibrosis progression in paired liver biopsies from HIV/HCV co-infected patients
    Schiavini, Monica
    Angeli, Elena
    Mainini, Annalisa
    Uberti-Foppa, Caterina
    Zerbi, Pietro
    Sagnelli, Caterina
    Cargnel, Antonietta
    Vago, Gianluca
    Duca, Pier Giorgio
    Giorgi, Riccardo
    Rizzardini, Giuliano
    Gubertini, Guido
    [J]. HEPATITIS MONTHLY, 2011, 11 (07) : 525 - 531
  • [42] Absence of liver steatosis in HIV-HCV co-infected patients receiving regimens containing tenofovir or abacavir
    Borghi, V.
    Bisi, L.
    Manzini, L.
    Cossarizza, A.
    Mussini, C.
    [J]. INFECTION, 2013, 41 (02) : 425 - 429
  • [43] Health related quality of life among HIV-HCV co-infected patients
    Preau, M.
    Protopopescu, C.
    Spire, B.
    Dellamonica, P.
    Poizot-Martin, I.
    Villes, V.
    Carrieri, M. -P.
    [J]. REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 2006, 54 : 1S33 - 1S43
  • [44] Impact of anti-HCV therapy after liver transplantation (LT) in HIV-HCV co-infected patients.
    Vallee, JCD
    Feray, C
    Afonso, AMR
    Castaing, D
    Samuel, D
    [J]. LIVER TRANSPLANTATION, 2005, 11 (07) : C17 - C17
  • [45] Hyperbilirubinaemia in HIV-HCV co-infected patients on antiretroviral therapy: drug effect or liver disease severity?
    Kaspar, Matthew B.
    Sterling, Richard K.
    [J]. BMJ OPEN GASTROENTEROLOGY, 2016, 3 (01):
  • [46] Histological damage in liver biopsy specimens from 492 HIV-HCV co-infected patients: A European collaborative study
    Romero, M
    Martin-Carbonero, L
    Benhamou, Y
    Puoti, M
    Rockstroh, J
    Arizcorreta, A
    Giron, JA
    Asensi, V
    Gonzalez, A
    Vogel, M
    Soriano, V
    Garcia-Samaniego, J
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 : 166 - 166
  • [47] Liver fibrosis regression in HIV-HCV co-infected individuals after sustained virologic response with HCV direct-acting antivirals
    Arias, Ana
    Lledo, Gemma
    Trevino, Ana
    Benitez-Gutierrez, Laura
    Carrasco, Itziar
    Cuervas-Mons, Valentin
    De Mendoza, Carmen
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [48] Comparison of liver fibrosis progression in HIV/HCV co-infected and HCV mono-infected patients by transient elastometry
    Mazzocato, Susanna
    Orsetti, Elena
    Gesuita, Rosaria
    Piraccini, Francesca
    Drenaggi, Davide
    Barchiesi, Francesco
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2014, 46 (11) : 797 - 802
  • [49] The influence of the PNPLA3 polymorphism on hepatic steatosis and fibrosis progression in HIV-HCV co-infected patients
    Payer, B.
    Reiberger, T.
    Stift, J.
    Ferenci, P.
    Peck-Radosavljevic, M.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2012, 124 (15-16) : 570 - 570
  • [50] Matrix stiffness regulate apoptotic cell death in HIV-HCV co-infected hepatocytes: Importance for liver fibrosis progression
    Ganesan, Murali
    Dagur, Raghubendra Singh
    Makarov, Edward
    Poluektova, Larisa I.
    Kidambi, Srivatsan
    Osna, Natalia A.
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 500 (03) : 717 - 722
12345